References:
[1] N. Mederos, A. Wolfer, P. Mathevet, M. Zaher, A. Sarivalasis, Le
cancer séreux de haut gradede l’ovaire en 2018 : avancéeset
controverses, Revue Médicale Suisse. 14 (2018) 1037–1041.
https://doi.org/10.53738/REVMED.2018.14.607.1037.
[2] N. Yahagi, Y. Kobayashi, T. Ohara, N. Suzuki, K. Kiguchi, B.
Ishizuka, Ovarian carcinoma complicated by sigmoid colon fistula
formation: A case report and review of the literature: Colon fistula
formation, Journal of Obstetrics and Gynaecology Research. 37 (2011)
250–253. https://doi.org/10.1111/j.1447-0756.2010.01341.x.
[3] The risk of gastrointestinal perforation and/or fistula in
patients with recurrent ovarian cancer receiving bevacizumab compared to
standard chemotherapy: A retrospective cohort study - Gynecologic
Oncology, (n.d.).
https://www.gynecologiconcology-online.net/article/S0090-8258(09)00377-1/fulltext
(accessed July 30, 2022).
[4] I. Ureyen, T. Toptas, S.A. Tatar, G. Ekin, F. Gulec, A. Uysal,
Jejunal Fistula Complicating Ovarian Serous Carcinoma: Case Report of a
Rare Phenomenon and Review of the Literature, Gynecol Obstet Reprod Med.
27 (2021) 184–186. https://doi.org/10.21613/GORM.2018.816.
[5] K.F. Børseth, G. Acharya, T. Kiserud, J. Trovik, Incidence of
gynecological fistula and its surgical treatment: A national
registry‐based study, Acta Obstet Gynecol Scand. 98 (2019) 1120–1126.
https://doi.org/10.1111/aogs.13611.
[6] Y. Kizaki, T. Nagai, K. Ohara, Y. Gomi, T. Akahori, Y. Ono, S.
Matsunaga, Y. Takai, M. Saito, K. Baba, H. Seki, Ovarian mature cystic
teratoma with fistula formation into the rectum: a case report,
SpringerPlus. 5 (2016) 1700. https://doi.org/10.1186/s40064-016-3426-4.
[7] K. Imamura, H. Nishimura, M. Takao, T. Maruuchi, Y. Ogou, Y.
Kiyozuka, Y. Muraoka, M. Yakushiji, Ovarian tumor complicated by a
colo-ovarian fistula, Oncol Rep. (1997).
https://doi.org/10.3892/or.4.6.1277.
[8] A. Shai, E. Grikshtas, Y. Segev, M. Moskovitz, A. Bitterman, M.
Steiner, O. Lavie, Conservative Management for an Entero-Adnexal Fistula
at Initial Presentation of Advanced Ovarian Carcinoma, Current Oncology.
20 (2013) 44–47. https://doi.org/10.3747/co.20.1196.
[9] (n.d.).
http://www.cngof.net/E-book/GO-2016/26-ch19-201-212-9782294715518-T-ovaire.html
(accessed July 29, 2022).
[10] M. Fournier, Morbidité des résections recto-sigmoïdiennes dans
la chirurgie de cytoréduction des cancers de l’ovaire, (n.d.) 48.